9/28/2011 7:58:48 AM
Biotrin Group, owned by Italian diagnostics company DiaSorin, has officially opened a new research, development and manufacturing facility in Dublin which will create up to 40 high-value positions over the next few years. A developer and manufacturer of diagnostic platform technology, the Biotrin Group announced a new R&D project in June 2010 to develop a molecular diagnostic platform technology and assay reagents for the detection of DNA in infectious disease and oncology. The new facility will allow the continuation of the R&D activity and the expansion of the manufacturing capability. The total number employed at the facility is expected to reach over 100.
comments powered by